Cara Therapeutics (CARA) PT Raised to $35 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq rise as chips recover, Broadcom gains on Apple deal
- Oil prices little changed as Saudi cuts prices, OPEC+ boosts target
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Broadcom secures role as key Apple supplier with chip deal through 2031
- Dara Khosrowshahi steps down from Grab Holdings board
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- S&P 500, Nasdaq rise as chips recover, Broadcom gains on Apple deal
Cara Therapeutics (CARA) FV Target Raised to $33 at Janney
May 29, 2019 3:40 PM EDTJanney analyst Esther Hong raised the fair value target on Cara Therapeutics (NASDAQ: CARA) to $33.00 (from $27.00) while maintaining a Buy rating following data.
The analyst commented, "Today's announcement of positive Ph.3 KALM-1 IV-Korsuva data demonstrating statistical significance on the primary and all... More
Cara Therapeutics (CARA) PT Raised to $33 at Jefferies
May 29, 2019 11:20 AM EDTJefferies analyst Chris Howerton raised the price target on Cara Therapeutics (NASDAQ: CARA) to $33.00 (from $25.00) while maintaining a Buy rating.
... MoreCara Therapeutics (CARA) PT Raised to $28 at H.C. Wainwright
May 29, 2019 10:55 AM EDTH.C. Wainwright analyst Oren Livnat raised the price target on Cara Therapeutics (NASDAQ: CARA) to $28.00 (from $26.00) while maintaining a Buy rating.
... More